044960 — Eagle Veterinary Technology Co Income Statement
0.000.00%
- KR₩66bn
- KR₩66bn
- KR₩43bn
- 90
- 31
- 20
- 42
Annual income statement for Eagle Veterinary Technology Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | — | — | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 34,423 | 40,357 | 40,437 | 43,540 | 42,794 |
Cost of Revenue | |||||
Gross Profit | 9,260 | 12,182 | 14,334 | 14,818 | 14,545 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 32,783 | 37,046 | 36,373 | 40,111 | 39,594 |
Operating Profit | 1,640 | 3,311 | 4,064 | 3,428 | 3,199 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,264 | 2,929 | 3,875 | 3,429 | 3,520 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,232 | 2,459 | 3,638 | 2,643 | 2,976 |
Net Income Before Extraordinary Items | |||||
Net Income | 1,232 | 2,459 | 3,638 | 2,643 | 2,976 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,232 | 2,459 | 3,638 | 2,643 | 2,976 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 101 | 199 | 296 | 214 | 243 |
Dividends per Share |